Octave Specialty Group (OSG) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
6 Jun, 2026Opening remarks and agenda
Meeting held virtually to maximize shareholder participation, with all board members in attendance and the agenda outlined at the start.
The meeting was officially called to order at 11:00 A.M. Eastern Time on May 28th, 2026.
Board and executive committee updates
Seven directors were nominated for election to serve until the next annual meeting.
No other nominations or proposals were received; nominations and proposals were closed.
Shareholder proposals
Four proposals presented: election of directors, advisory vote on executive compensation, ratification of Ernst & Young as auditor for 2026, and approval of the 2026 Incentive Compensation Plan.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Octave Specialty Group
- Revenue and premium up sharply, but net loss widened; Legacy/AAC sale pending approval.OSG
Q1 20258 Jul 2026 - Transformation completed, compensation aligned, and Board urges support for all proxy proposals.OSG
Proxy filing14 May 2026 - Insurance Distribution revenue up 92%, total revenue up 66%, and adjusted EBITDA surged.OSG
Q1 20267 May 2026 - Shareholders to vote on board, compensation, auditor, and new incentive plan after major transformation.OSG
Proxy filing10 Apr 2026 - Board recommends approval of all annual meeting proposals, including director elections and compensation.OSG
Proxy filing10 Apr 2026 - Q4 2025 delivered strong premium and revenue growth, but net loss rose on acquisition costs.OSG
Q4 202524 Feb 2026 - AAC sale and Beat acquisition accelerate specialty P&C transformation and capital redeployment.OSG
Q2 20242 Feb 2026 - Legacy business sold to Oaktree and 60% of Beat acquired, accelerating specialty P&C focus.OSG
Investor Update31 Jan 2026 - Q3 net loss, 86% P&C premium growth, Beat acquisition, $50M buyback, legacy sale approved.OSG
Q3 202414 Jan 2026